An observational study in Osteoarthritis, Knee, sponsored by Ganymed Robotics. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-11-18.
Sponsored by Ganymed Robotics · Observational
Ganymed Robotics develops a novel solution of surgical navigation to assist surgeons during knee remplacement surgeries. The aim of this study is to train and validate this novel algorithm.
During knee replacement surgery, per-operative images of the patient's knee will be taken. These images will then be compared with the pre-operative CT-scan of the patient using the novel navigation algorithm. The algorithm will be validated based on its ability to correctly compare both modalities (pre-operative and per-operative images).
4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.
This study's enrollment of 100 is close to the median of 100 across 791 observational studies indexed under Osteoarthritis.
Browse Osteoarthritis studies →This is the only study on the registry with Ganymed Robotics as lead sponsor.
Counted across the registry records on this site, refreshed daily.
The surgeons involved in the study will propose to all patients corresponding to the eligibility criteria to participate to the study during pre-surgery appointment.
Exclusion Criteria:
Images taken during knee replacement surgery will be compared to CT-Scan that was performed before surgery
Also known as: CT-Scan before knee replacement surgery
Validation of navigation algorithm
Comparison between peroperative images and preoperative CT-scan
Time frame: 12 months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.